Report

TABLE OF CONTENTS
1 INTRODUCTION 44
1.1 OBJECTIVES OF THE STUDY 44
1.2 MARKET DEFINITION 44
1.3 OVERVIEW OF GLOBAL PET-CT SCANNING SERVICES MARKET 44
1.4 LIMITATIONS 46
1.5 MARKETS COVERED 47
2 MARKET SEGMENTATION 49
2.1 MARKETS COVERED 49
2.2 GEOGRAPHICAL SCOPE 50
2.3 YEARS CONSIDERED FOR THE STUDY 51
2.4 CURRENCY AND PRICING 51
2.5 DBMR TRIPOD DATA VALIDATION MODEL 52
2.6 MULTIVARIATE MODELLING 55
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 56
2.8 DBMR MARKET POSITION GRID 57
2.9 MARKET APPLICATION COVERAGE GRID 58
2.10 VENDOR SHARE ANALYSIS 59
2.11 SECONDARY SOURCES 60
2.12 ASSUMPTIONS 60
3 EXECUTIVE SUMMARY 61
4 PREMIUM INSIGHTS 68
4.1 PORTER'S FIVE FORCES 70
4.2 INNOVATION TRACKER AND STRATEGIC ANALYSIS 71
4.2.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS 71
4.2.1.1 JOINT VENTURES 71
4.2.1.2 MERGERS AND ACQUISITIONS 71
4.2.1.3 LICENSING AND PARTNERSHIP 71
4.2.1.4 TECHNOLOGY COLLABORATIONS 71
4.2.1.5 STRATEGIC DIVESTMENTS 71
4.2.2 NUMBER OF PRODUCTS IN DEVELOPMENT 71
4.2.3 STAGE OF DEVELOPMENT 72
4.2.4 TIMELINES AND MILESTONES 72
4.2.5 INNOVATION STRATEGIES AND METHODOLOGIES 72
4.2.6 RISK ASSESSMENT AND MITIGATION 72
4.2.7 FUTURE OUTLOOK 72
4.3 PRICING ANALYSIS 73
4.4 SUPPLY CHAIN ANALYSIS - GLOBAL PET-CT SCANNING SERVICES MARKET 74
4.4.1 RADIOTRACER & ISOTOPE PRODUCTION 74
4.4.2 RADIOPHARMACY COMPOUNDING, QC & DISTRIBUTION 74
4.4.3 PET-CT SCANNER MANUFACTURING, INSTALLATION & SERVICE SUPPORT 74
4.4.4 IMAGING FACILITY OPERATIONS (HOSPITALS, INDEPENDENT CENTERS & MOBILE UNITS) 74
4.4.5 CLINICAL WORKFLOW, SCHEDULING & REFERRER INTERFACE 74
4.4.6 DATA MANAGEMENT, REPORTING & ARCHIVING 75
4.4.7 PAYERS, REIMBURSEMENT & REGULATORY OVERSIGHT 75
4.4.8 BOTTLENECKS, RISKS & STRATEGIC RESPONSES 75
4.5 VALUE CHAIN ANALYSIS 76
4.5.1 OVERVIEW 76
4.5.2 RAW MATERIAL SUPPLY 76
4.5.3 COMPONENT MANUFACTURING AND PROCESSING 76
4.5.4 EQUIPMENT & TECHNOLOGY PROVIDERS 76
4.5.5 DISTRIBUTION AND LOGISTICS 77
4.5.6 END-USERS (PROVIDERS & CLINICAL SECTORS) 77
4.5.7 CONCLUSION 77
5 TARIFFS & IMPACT ON THE MARKET 78
5.1 CURRENT TARIFF RATES IN TOP-5 COUNTRY MARKETS 78
5.2 OUTLOOK: LOCAL PRODUCTION VS. IMPORT RELIANCE 78
5.3 VENDOR SELECTION CRITERIA DYNAMICS 78
5.4 IMPACT ON SUPPLY CHAIN 79
5.4.1 RAW MATERIAL PROCUREMENT 79
5.4.2 MANUFACTURING AND PRODUCTION 79
5.4.3 LOGISTICS AND DISTRIBUTION 79
5.4.4 PRICE PITCHING AND MARKET POSITION 79
5.5 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 79
5.5.1 SUPPLY CHAIN OPTIMIZATION 79
5.5.2 JOINT VENTURE ESTABLISHMENTS 79
5.6 IMPACT ON PRICES 79
5.7 REGULATORY INCLINATION 80
5.7.1 GEOPOLITICAL SITUATION 80
5.7.2 TRADE PARTNERSHIPS BETWEEN COUNTRIES 80
5.7.3 FREE TRADE AGREEMENTS & ALLIANCES 80
5.7.4 DOMESTIC COURSE OF CORRECTION 80
6 MARKET OVERVIEW 81
6.1 DRIVERS 83
6.1.1 INCREASING INCIDENCE OF CANCER AND NEUROLOGICAL DISORDERS 83
6.1.2 EXPANSION OF GLOBAL HEALTHCARE INFRASTRUCTURE 83
6.1.3 INCREASING AWARENESS ABOUT EARLY DIAGNOSIS 84
6.1.4 GROWING PREFERENCE FOR HYBRID IMAGING TECHNIQUES 85
6.2 RESTRAINS 86
6.2.1 HIGH COST OF PET-CT PROCEDURES AND LIMITED REIMBURSEMENT 86
6.2.2 LACK OF SKILLED RADIOLOGISTS AND TECHNOLOGISTS 87
6.3 OPPORTUNITIES 88
6.3.1 EXPANSION IN EMERGING MARKETS SUCH AS ASIA-PACIFIC AND MIDDLE EAST 88
6.3.2 DEVELOPMENT OF MOBILE OR DECENTRALIZED PET-CT SERVICES 89
6.3.3 NEW CLINICAL APPLICATIONS AND TECHNOLOGICAL ADVANCEMENTS IN PET-CT IMAGING 90
6.4 CHALLENGES 91
6.4.1 OPERATIONAL CHALLENGES IN PUBLIC SECTOR HOSPITALS 91
6.4.2 REGULATORY AND DATA PRIVACY CONCERNS 92
7 GLOBAL PET-CT SCANNING SERVICES MARKET, BY SERVICE TYPE 93
7.1 OVERVIEW 94
7.2 GLOBAL PET-CT SCANNING SERVICES MARKET, BY SERVICE TYPE, 2018-2033 (USD THOUSAND) 97
7.2.1 STANDALONE PET-CT SCANNING SERVICES 97
7.2.2 ONSITE PET-CT SCANNING SERVICES 97
7.2.3 MOBILE PET-CT SCANNING SERVICES 97
7.3 GLOBAL STANDALONE PET-CT SCANNING SERVICES IN PET-CT SCANNING SERVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND) 98
7.3.1 OUTPATIENT SERVICES 98
7.3.2 INPATIENT SERVICES 98
7.4 GLOBAL OUTPATIENT SERVICES IN PET-CT SCANNING SERVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND) 99
7.4.1 INDEPENDENT IMAGING CENTERS 99
7.4.2 HOSPITAL-BASED OUTPATIENT 99
7.5 GLOBAL INPATIENT SERVICES IN PET-CT SCANNING SERVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND) 100
7.5.1 GENERAL HOSPITALS 100
7.5.2 SPECIALTY HOSPITALS 100
7.5.3 DIAGNOSTIC CENTERS 100
7.6 GLOBAL STANDALONE PET-CT SCANNING SERVICES IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 101
7.6.1 NORTH AMERICA 101
7.6.2 EUROPE 101
7.6.3 ASIA-PACIFIC 101
7.6.4 SOUTH AMERICA 101
7.6.5 MIDDLE EAST AND AFRICA 102
7.7 GLOBAL ONSITE PET-CT SCANNING SERVICES IN PET-CT SCANNING SERVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND) 102
7.7.1 TERTIARY CARE HOSPITALS 102
7.7.2 ACADEMIC MEDICAL CENTERS 102
7.7.3 OTHERS 102
7.8 GLOBAL ONSITE PET-CT SCANNING SERVICES IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 103
7.8.1 NORTH AMERICA 103
7.8.2 EUROPE 103
7.8.3 ASIA-PACIFIC 103
7.8.4 SOUTH AMERICA 103
7.8.5 MIDDLE EAST AND AFRICA 104
7.9 GLOBAL MOBILE PET-CT SCANNING SERVICES IN PET-CT SCANNING SERVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND) 104
7.9.1 RURAL OUTREACH INITIATIVES 104
7.9.2 PUBLIC HEALTH PROGRAMS 104
7.9.3 CORPORATE HEALTH CHECK-UP CAMPS 104
7.10 GLOBAL MOBILE PET-CT SCANNING SERVICES IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 105
7.10.1 NORTH AMERICA 105
7.10.2 EUROPE 105
7.10.3 ASIA-PACIFIC 105
7.10.4 SOUTH AMERICA 106
7.10.5 MIDDLE EAST AND AFRICA 106
8 GLOBAL PET-CT SCANNING SERVICES MARKET, BY SCAN TYPE 107
8.1 OVERVIEW 108
8.2 GLOBAL PET-CT SCANNING SERVICES MARKET, BY SCAN TYPE, 2018-2033 (USD THOUSAND) 111
8.3 WHOLE BODY SCANS 111
8.3.1 PARTIAL BODY SCANS 111
8.4 GLOBAL WHOLE BODY SCANS IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 112
8.4.1 NORTH AMERICA 112
8.4.2 EUROPE 112
8.4.3 ASIA-PACIFIC 112
8.4.4 SOUTH AMERICA 112
8.4.5 MIDDLE EAST AND AFRICA 113
8.5 GLOBAL PARTIAL BODY SCANS IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 113
8.5.1 NORTH AMERICA 113
8.5.2 EUROPE 113
8.5.3 ASIA-PACIFIC 113
8.5.4 SOUTH AMERICA 114
8.5.5 MIDDLE EAST AND AFRICA 114
9 GLOBAL PET-CT SCANNING SERVICES MARKET, BY TRACER TYPE 115
9.1 OVERVIEW 116
9.2 GLOBAL PET-CT SCANNING SERVICES MARKET, BY TRACER TYPE, 2018-2033 (USD THOUSAND) 119
9.2.1 FDG (FLUORODEOXYGLUCOSE) 119
9.2.2 NON-FDG TRACERS 119
9.2.3 NEW/EMERGING TRACERS 119
9.3 GLOBAL FDG (FLUORODEOXYGLUCOSE) IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 120
9.3.1 NORTH AMERICA 120
9.3.2 EUROPE 120
9.3.3 ASIA-PACIFIC 120
9.3.4 SOUTH AMERICA 120
9.3.5 MIDDLE EAST AND AFRICA 121
9.4 GLOBAL NON-FDG TRACERS IN PET-CT SCANNING SERVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND) 121
9.4.1 DOTATATE 121
9.4.2 CHOLINE 121
9.4.3 FLUOROTHYMIDINE 121
9.4.4 OTHERS (GA-68, AMMONIA) 121
9.5 GLOBAL NON-FDG TRACERS IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 122
9.5.1 NORTH AMERICA 122
9.5.2 EUROPE 122
9.5.3 ASIA-PACIFIC 122
9.5.4 SOUTH AMERICA 122
9.5.5 MIDDLE EAST AND AFRICA 123
9.6 GLOBAL NEW/EMERGING TRACERS IN PET-CT SCANNING SERVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND) 123
9.6.1 PSMA 123
9.6.2 FAPI 123
9.7 GLOBAL NEW/EMERGING TRACERS IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 124
9.7.1 NORTH AMERICA 124
9.7.2 EUROPE 124
9.7.3 ASIA-PACIFIC 124
9.7.4 SOUTH AMERICA 125
9.7.5 MIDDLE EAST AND AFRICA 125
10 GLOBAL PET-CT SCANNING SERVICES MARKET, BY APPLICATION 126
10.1 OVERVIEW 127
10.2 GLOBAL PET-CT SCANNING SERVICES MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND) 130
10.2.1 ONCOLOGY 130
10.2.2 NEUROLOGY 130
10.2.3 CARDIOLOGY 130
10.2.4 INFECTIOUS DISEASES 131
10.2.5 INFLAMMATORY DISEASES 131
10.2.6 OTHERS (ORTHOPEDIC, PEDIATRICS) 131
10.3 GLOBAL ONCOLOGY IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 132
10.3.1 NORTH AMERICA 132
10.3.2 EUROPE 132
10.3.3 ASIA-PACIFIC 132
10.3.4 SOUTH AMERICA 132
10.3.5 MIDDLE EAST AND AFRICA 133
10.4 GLOBAL NEUROLOGY IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 133
10.4.1 NORTH AMERICA 133
10.4.2 EUROPE 133
10.4.3 ASIA-PACIFIC 133
10.4.4 SOUTH AMERICA 134
10.4.5 MIDDLE EAST AND AFRICA 134
10.5 GLOBAL CARDIOLOGY IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 134
10.5.1 NORTH AMERICA 134
10.5.2 EUROPE 134
10.5.3 ASIA-PACIFIC 135
10.5.4 SOUTH AMERICA 135
10.5.5 MIDDLE EAST AND AFRICA 135
10.6 GLOBAL INFECTIOUS DISEASES IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 136
10.6.1 NORTH AMERICA 136
10.6.2 EUROPE 136
10.6.3 ASIA-PACIFIC 136
10.6.4 SOUTH AMERICA 136
10.6.5 MIDDLE EAST AND AFRICA 137
10.7 GLOBAL INFLAMMATORY DISEASES IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 137
10.7.1 NORTH AMERICA 137
10.7.2 EUROPE 137
10.7.3 ASIA-PACIFIC 137
10.7.4 SOUTH AMERICA 138
10.7.5 MIDDLE EAST AND AFRICA 138
10.8 GLOBAL OTHERS IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 138
10.8.1 NORTH AMERICA 138
10.8.2 EUROPE 138
10.8.3 ASIA-PACIFIC 139
10.8.4 SOUTH AMERICA 139
10.8.5 MIDDLE EAST AND AFRICA 139
11 GLOBAL PET-CT SCANNING SERVICES MARKET, BY END USER 140
11.1 OVERVIEW 141
11.2 GLOBAL PET-CT SCANNING SERVICES MARKET, BY END USER, 2018-2033 (USD THOUSAND) 144
11.2.1 HOSPITALS 144
11.2.2 DIAGNOSTIC IMAGING CENTERS 144
11.2.3 SPECIALTY CLINICS 144
11.2.4 RESEARCH INSTITUTES 144
11.2.5 OTHERS 145
11.3 GLOBAL HOSPITALS IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 145
11.3.1 NORTH AMERICA 145
11.3.2 EUROPE 145
11.3.3 ASIA-PACIFIC 145
11.3.4 SOUTH AMERICA 146
11.3.5 MIDDLE EAST AND AFRICA 146
11.4 GLOBAL DIAGNOSTIC IMAGING CENTERS IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 146
11.4.1 NORTH AMERICA 146
11.4.2 EUROPE 146
11.4.3 ASIA-PACIFIC 147
11.4.4 SOUTH AMERICA 147
11.4.5 MIDDLE EAST AND AFRICA 147
11.5 GLOBAL SPECIALTY CLINICS IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 148
11.5.1 NORTH AMERICA 148
11.5.2 EUROPE 148
11.5.3 ASIA-PACIFIC 148
11.5.4 SOUTH AMERICA 148
11.5.5 MIDDLE EAST AND AFRICA 149
11.6 GLOBAL RESEARCH INSTITUTES IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 149
11.6.1 NORTH AMERICA 149
11.6.2 EUROPE 149
11.6.3 ASIA-PACIFIC 149
11.6.4 SOUTH AMERICA 150
11.6.5 MIDDLE EAST AND AFRICA 150
11.7 GLOBAL OTHERS IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 150
11.7.1 NORTH AMERICA 150
11.7.2 EUROPE 150
11.7.3 ASIA-PACIFIC 151
11.7.4 SOUTH AMERICA 151
11.7.5 MIDDLE EAST AND AFRICA 151
12 GLOBAL PET-CT SCANNING SERVICES MARKET, BY DISTRIBUTION CHANNEL 152
12.1 OVERVIEW 153
12.2 GLOBAL PET-CT SCANNING SERVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND) 156
12.2.1 DIRECT 156
12.2.2 INDIRECT 156
12.3 GLOBAL DIRECT IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 157
12.3.1 NORTH AMERICA 157
12.3.2 EUROPE 157
12.3.3 ASIA-PACIFIC 157
12.3.4 SOUTH AMERICA 157
12.3.5 MIDDLE EAST AND AFRICA 158
12.4 GLOBAL INDIRECT IN PET-CT SCANNING SERVICES MARKET, BY REGION, 2018-2033 (USD THOUSAND) 158
12.4.1 NORTH AMERICA 158
12.4.2 EUROPE 158
12.4.3 ASIA-PACIFIC 158
12.4.4 SOUTH AMERICA 159
12.4.5 MIDDLE EAST AND AFRICA 159
13 GLOBAL PET-CT SCANNING SERVICES MARKET, BY REGION 160
13.1 OVERVIEW 161
13.2 NORTH AMERICA 164
13.2.1 U.S. 170
13.2.2 CANADA 175
13.2.3 MEXICO 180
13.3 EUROPE 185
13.3.1 ITALY 196
13.3.2 FRANCE 201
13.3.3 U.K. 206
13.3.4 SPAIN 211
13.3.5 NETHERLANDS 216
13.3.6 BELGIUM 221
13.3.7 SWITZERLAND 226
13.3.8 RUSSIA 231
13.3.9 TURKEY 236
13.3.10 REST OF EUROPE 241
13.4 ASIA-PACIFIC 246
13.4.1 CHINA 252
13.4.2 JAPAN 257
13.4.3 INDIA 262
13.4.4 SOUTH KOREA 267
13.4.5 AUSTRALIA 272
13.4.6 THAILAND 277
13.4.7 SINGAPORE 282
13.4.8 INDONESIA 287
13.4.9 MALAYSIA 292
13.4.10 PHILIPPINES 297
13.4.11 REST OF ASIA-PACIFIC 302
13.5 SOUTH AMERICA 307
13.5.1 BRAZIL 313
13.5.2 ARGENTINA 318
13.5.3 REST OF SOUTH AMERICA 323
13.6 MIDDLE EAST AND AFRICA 328
13.6.1 EGYPT 334
13.6.2 SAUDI ARABIA 339
13.6.3 UAE 344
13.6.4 SOUTH AFRICA 349
13.6.5 ISRAEL 354
13.6.6 REST OF MEA 359
14 GLOBAL PET-CT SCANNING SERVICES MARKET: COMPANY LANDSCAPE 364
14.1 COMPANY SHARE ANALYSIS: GLOBAL 364
14.2 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 365
14.3 COMPANY SHARE ANALYSIS: NORTH AMERICA 366
14.4 COMPANY SHARE ANALYSIS: EUROPE 367
15 SWOT ANALYSIS 368
16 COMPANY PROFILE 369
16.1 C-HCA, INC. 369
16.1.1 COMPANY SNAPSHOT 369
16.1.2 REVENUE ANALYSIS 370
16.1.3 COMPANY SHARE ANALYSIS 370
16.1.4 PRODUCT PORTFOLIO 371
16.1.5 RECENT DEVELOPMENT 371
16.2 SIEMENS HEALTHINEERS AG 372
16.2.1 COMPANY SNAPSHOT 372
16.2.2 REVENUE ANALYSIS 372
16.2.3 COMPANY SHARE ANALYSIS 373
16.2.4 PRODUCT PORTFOLIO 373
16.2.5 RECENT DEVELOPMENT 373
16.3 RADNET INC. 374
16.3.1 COMPANY SNAPSHOT 374
16.3.2 REVENUE ANALYSIS 375
16.3.3 COMPANY SHARE ANALYSIS 375
16.3.4 PRODUCT PORTFOLIO 376
16.3.5 RECENT DEVELOPMENT 376
16.4 GENESISCARE 377
16.4.1 COMPANY SNAPSHOT 377
16.4.2 COMPANY SHARE ANALYSIS 377
16.4.3 PRODUCT PORTFOLIO 378
16.4.4 RECENT DEVELOPMENT 378
16.5 I-MED RADIOLOGY NETWORK 379
16.5.1 COMPANY SNAPSHOT 379
16.5.2 COMPANY SHARE ANALYSIS 379
16.5.3 PRODUCT PORTFOLIO 380
16.5.4 RECENT DEVELOPMENT 381
16.6 ALLIANCE-HNI HEALTH CARE SERVICES 382
16.6.1 COMPANY SNAPSHOT 382
16.6.2 PRODUCT PORTFOLIO 382
16.6.3 RECENT DEVELOPMENT 382
16.7 ALLIANCE MEDICAL LIMITED 383
16.7.1 COMPANY SNAPSHOT 383
16.7.2 PRODUCT PORTFOLIO 383
16.7.3 RECENT DEVELOPMENT 384
?
16.8 APOLLO HOSPITALS ENTERPRISES LTD. 385
16.8.1 COMPANY SNAPSHOT 385
16.8.2 REVENUE ANALYSIS 385
16.8.3 PRODUCT PORTFOLIO 386
16.8.4 RECENT DEVELOPMENT 386
16.9 CAPITOL IMAGING SERVICES 387
16.9.1 COMPANY SNAPSHOT 387
16.9.2 PRODUCT PORTFOLIO 387
16.9.3 RECENT DEVELOPMENT 387
16.10 CARDIAC IMAGING, INC 388
16.10.1 COMPANY SNAPSHOT 388
16.10.2 PRODUCT PORTFOLIO 388
16.10.3 RECENT DEVELOPMENT 388
16.11 CIRCLE HEALTH GROUP LTD 389
16.11.1 COMPANY SNAPSHOT 389
16.11.2 PRODUCT PORTFOLIO 389
16.11.3 RECENT DEVELOPMENT 390
16.12 COBALT HEALTH 391
16.12.1 COMPANY SNAPSHOT 391
16.12.2 PRODUCT PORTFOLIO 391
16.12.3 RECENT DEVELOPMENT 392
16.13 DIGNITY HEALTH 393
16.13.1 COMPANY SNAPSHOT 393
16.13.2 PRODUCT PORTFOLIO 393
16.13.3 RECENT DEVELOPMENT 393
16.14 DMS HEALTH 394
16.14.1 COMPANY SNAPSHOT 394
16.14.2 PRODUCT PORTFOLIO 394
16.14.3 RECENT DEVELOPMENT 395
16.15 FORTIS HEALTHCARE 396
16.15.1 COMPANY SNAPSHOT 396
16.15.2 REVENUE ANALYSIS 397
16.15.3 PRODUCT PORTFOLIO 397
16.15.4 RECENT DEVELOPMENT 398
16.16 INHEALTH GROUP 399
16.16.1 COMPANY SNAPSHOT 399
16.16.2 PRODUCT PORTFOLIO 399
16.16.3 RECENT DEVELOPMENT 400
?
16.17 MEDICA GROUP LTD (SUBSIDIARY OF MEDICA GROUP) 401
16.17.1 COMPANY SNAPSHOT 401
16.17.2 PRODUCT PORTFOLIO 401
16.17.3 RECENT DEVELOPMENT 402
16.18 NM MEDICAL 403
16.18.1 COMPANY SNAPSHOT 403
16.18.2 PRODUCT PORTFOLIO 403
16.18.3 RECENT DEVELOPMENT 403
16.19 NUECLEAR 404
16.19.1 COMPANY SNAPSHOT 404
16.19.2 PRODUCT PORTFOLIO 404
16.19.3 RECENT DEVELOPMENT 405
16.20 SHARED MEDICAL SERVICES INC. 406
16.20.1 COMPANY SNAPSHOT 406
16.20.2 PRODUCT PORTFOLIO 406
16.20.3 RECENT DEVELOPMENT 407
17 QUESTIONNAIRE 408
18 RELATED REPORTS 411
?